Zomedica Corp. (ZOMDF): EPS (Diluted)
-$0.08
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.08 | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | -$0.05 | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$0.04 | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | -$0.02 | n/a | 2024-04-01, From 2022-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Zomedica Corp. (ZOMDF) | 2025-12-31 | -$0.08 | n/m |
| Verastem, Inc. (VSTM) | 2025-12-31 | -$3.02 | n/m |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | -$1.18 | n/m |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | -$1.68 | n/m |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $0.012 | +9.1% |
| Sunshine Biopharma Inc. (SBFM) | 2024-12-31 | -$7.32 | n/m |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | -$1.68 | n/m |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | -$0.28 | n/m |
| BGM Group Ltd. (BGM) | 2025-09-30 | -$0.18 | n/m |
Compare ZOMDF, VSTM, FHTX, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗